Clinical Trial

Efficacy and Safety of OsrhCT and Dimethicone Emulsion Before Upper Endoscopy on Visualization of the Gastric Mucosa.

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2025 (before its estimated May 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
Study was designed to evaluate efficacy of OsrhCT and Dimethicone emulsion before upper endoscopy on visibility of gastric mucosa. A total of 336 subjects (both male and female) are expected to be enrolled in this trial.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-12-03; most recent amendment 2025-04-27.
Status change: Recruiting → Active, Not Recruiting 2025-04-27
Status change: Not Yet Recruiting → Recruiting 2024-12-22
Trial Details
NCT Number NCT06722664
Lead Sponsor Healthgen Biotechnology Corp.
Collaborators: Beijing Friendship Hospital
Conditions Gastric Mucosal Lesion
Enrollment 336 participants
Start Date 2024-12-19
Primary Completion 2025-05-15 (estimated)
Study Completion 2025-05-15 (estimated)
Updated on ClinicalTrials.gov 2025-04-29